Literature DB >> 34039501

Adherence to a Mediterranean diet, dyslipidemia and inflammation in familial hypercholesterolemia.

Luiza Antoniazzi1, Raquel Arroyo-Olivares2, Marcio S Bittencourt3, Mauricio T Tada1, Isabella Lima1, Cinthia E Jannes1, Jose E Krieger1, Alexandre C Pereira1, Gracia Quintana-Navarro4, Ovidio Muñiz-Grijalvo5, José L Díaz-Díaz6, Rodrigo Alonso7, Pedro Mata2, Raul D Santos8.   

Abstract

BACKGROUND AND AIMS: Familial Hypercholesterolemia (FH) is characterized by elevated LDL-cholesterol (LDL-C) and high atherosclerosis risk. The impact of different dietary patterns on atherosclerosis biomarkers has been poorly studied in FH. This study verified the association of adherence to a Mediterranean diet with biomarkers of dyslipidemia and low-grade inflammation in molecularly proven FH adults from Brazil (BR) and Spain (SP). METHODS AND <br> RESULTS: In this cross-sectional study adherence to the Mediterranean diet was assessed by a validated score and generalized estimating equations were used to evaluate its association with plasma LDL-C, apolipoprotein-B (ApoB) and high sensitivity C-reactive protein (hs-CRP) concentrations. We included 92 (mean age 45 years, 58.7% females) and 98 FH individuals (mean age 46.8 years, 60.2% females) respectively from BR and SP. FH causing variants did not differ between countries. LDL-C, ApoB and hs-CRP concentrations were higher in BR than in SP: 179 (135-250) and 161 (133-193) mg/dL; 141 (109-181) and 103 (88-134) mg/dL; and 1.6 (0.8-4.0) and 0.8 (0.4-1.5) mg/L respectively (all p < 0.001). Most of BR had low adherence (n = 77, 83.7%), while the majority of SP were divided into moderate (n = 35, 35.7%) and strong adherence to the Mediterranean diet (n = 37, 37.8%), p < 0.001. There was a significant inverse association of adherence to the Mediterranean diet score with higher LDL-C, ApoB, and hs-CRP after adjusting for socio economic parameters, caloric and fatty acid intakes as well as pharmacological lipid lowering therapies. <br> CONCLUSIONS: Higher adherence to a Mediterranean diet was associated with better dyslipidemia and low-grade inflammation profiles in FH.
Copyright © 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular diseases; Cholesterol; Familial hypercholesterolemia; Hyperliproteinemia type II; Inflammation; Mediterranean diet

Year:  2021        PMID: 34039501     DOI: 10.1016/j.numecd.2021.04.006

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  6 in total

Review 1.  Mediterranean Diet and Obesity-related Disorders: What is the Evidence?

Authors:  Giovanna Muscogiuri; Ludovica Verde; Cem Sulu; Niki Katsiki; Maria Hassapidou; Evelyn Frias-Toral; Gabriela Cucalón; Agnieszka Pazderska; Volkan Demirhan Yumuk; Annamaria Colao; Luigi Barrea
Journal:  Curr Obes Rep       Date:  2022-09-30

Review 2.  Application of Mediterranean Diet in Cardiovascular Diseases and Type 2 Diabetes Mellitus: Motivations and Challenges.

Authors:  Najwa Salim AlAufi; Yoke Mun Chan; Mostafa I Waly; Yit Siew Chin; Barakatun-Nisak Mohd Yusof; Norliza Ahmad
Journal:  Nutrients       Date:  2022-07-05       Impact factor: 6.706

Review 3.  Intestinal Alkaline Phosphatase: A Review of This Enzyme Role in the Intestinal Barrier Function.

Authors:  Gilberto Maia Santos; Shámila Ismael; Juliana Morais; João R Araújo; Ana Faria; Conceição Calhau; Cláudia Marques
Journal:  Microorganisms       Date:  2022-03-30

4.  Long-Term Adherence to a Mediterranean Diet 1-Year after Completion of the MedLey Study.

Authors:  Karen J Murphy; Kathryn A Dyer; Belinda Hyde; Courtney R Davis; Ella L Bracci; Richard J Woodman; Jonathan M Hodgson
Journal:  Nutrients       Date:  2022-07-28       Impact factor: 6.706

Review 5.  Mediterranean Diet and Its Association with Cardiovascular Disease Risk Factors: A Scoping Review.

Authors:  Leigh Ann Richardson; Kenneth Izuora; Arpita Basu
Journal:  Int J Environ Res Public Health       Date:  2022-10-06       Impact factor: 4.614

Review 6.  Hypertension and Dyslipidemia Combined Therapeutic Approaches.

Authors:  Claudio Borghi; Federica Fogacci; Davide Agnoletti; Arrigo F G Cicero
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.